IL-13 overexpression has been found in both lesional and non-lesional skin of AD patients (Tsoi et al., 2019) and its levels correlate with AD disease severity (Szegedi et al., 2015; Guttman-Yassky et al., 2019; Tsoi et al., 2019). Here, IL13 is linked to Alzheimer disease.